Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
'Economy class syndrome' is a medical issue that can happen on flights — no matter where you sit
This government-backed startup is growing blood to help fight shortages
All Star Family Orthodontics: Leading the Way in Personalized, Comfortable Orthodontic Care in Old Bridge, NJ
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
